Assessment of dipyridamole stress echocardiography for risk stratification of diabetic patients. Issue 1 (December 2015)

• Record Type: Journal Article
• Authors: Baroncini, Liz; Borsoi, Rafael; Vidal, Maria; Valente, Nathália; Veloso, Juliana; Pecoits Filho, Roberto
• Is Part Of: Cardiovascular ultrasound. Volume 13:Issue 1(2015)
• Page Start: 1
• Page End: 7
• Publication Date: 2015-12
• Subjects: Stress echocardiography -- Diabetes mellitus -- Coronary artery disease; Echocardiography -- Periodicals; Intravascular ultrasonography -- Periodicals; Cardiovascular system -- Diseases -- Periodicals; 616.1207543
• DOI: 10.1186/s12947-015-0030-7
• Languages: English
• ISSNs: 1476-7120

Abstract

Abstract Background Despite advances in medical therapy, cardiovascular disease, mainly coronary artery disease (CAD), remains the leading cause of mortality among patients with diabetes mellitus (DM). The objective of the present study was to assess the effectiveness of dipyridamole stress echocardiography in identify diabetic patients at high risk for cardiovascular events. Methods Dipyridamole stress echocardiography was administered to 483 diabetic patients (294 women; mean age 63.41 ± 11.28 years) between July 2006 and December 2012. Results Follow-up data were available for 264 patients (163 women; mean age 64.3 ± 10.5 years): 250 with a negative stress echocardiography and 14 with a positive stress echo. During a mean follow-up time of 18 ± 14 months, a cardiovascular event occurred in 18 (6.8 %) patients, 12 (4.8 %) in patients with a negative stress echo (n = 250) during a mean follow-up period of 20 ± 16 months and 6 (42 %) in patients with positive stress echo (n = 14) during a mean follow-up of 13 ± 13 months. The positive and negative predictive values of stress echocardiography were 42 % and 96 % respectively. The accuracy value was 92 %. A Cox regression model showed that CAD (hazard ratio [HR] 5.4, 95 % confidence interval [CI] 1.9-15.4;p = 0.002) and positive stress echocardiography (HR 7.1, 95 % CI 2.5-20.5;p < 0.001) were significant predictors of cardiovascular events. Conclusions For patients with diabetes, a negative dipyridamole stress echocardiogram predicts favorable outcome during the first year of follow-up. A new stress imaging test should be done after 12 months in diabetic patients.